Impact of HLA-dpb1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms

Biology of Blood and Marrow Transplantation

Volumn 18, Issue 4, 2012, Pages 608-616

  Bettens, Florence ^a   Passweg, Jakob ^a   Schanz, Urs ^b   Chalandon, Yves ^a   Heim, Dominik ^c   Güngör, Tayfun ^d   Stussi, Georg ^b   Nicoloso, Grazia ^e   Baldomero, Helen ^c   Gratwohl, Alois ^c   Tiercy, Jean Marie ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d Kindersspital Zürich   (Switzerland)

^e Swiss Blood Stem Cells Registry   (Switzerland)

Author keywords

HLA haplotype matching; HLA DP; HSCT; Microsatellite; TNFd locus; Unrelated donor

Indexed keywords

HLA DPB1 ANTIGEN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR DELTA; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HAZARD RATIO; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HLA TYPING; HUMAN; IMMUNE RESPONSE; LYMPHOMA; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROSATELLITE INSTABILITY; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; ORGAN DONOR; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; T CELL DEPLETION; UNRELATED DONORS;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-DP BETA-CHAINS; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK; TUMOR NECROSIS FACTOR-ALPHA; UNRELATED DONORS; YOUNG ADULT;

EID: 84858055098     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.09.011     Document Type: Article

References (42)

1. Petersdorf E.W. Optimal HLA matching in haematopoietic stem cell transplantation. Curr Opin Immunol 2008, 20:588-593.
2. Tiercy J.-M., Nicoloso de Faveri G., Passweg J., et al. The probability to identify a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant 2007, 40:515-520.
3. Gooley T.A., Chien J.W., Pergam S.A., et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010, 363:2091-2101.
4. Gratwohl A., Baldomero H., Frauendorfer K., Urbano-Ispizua A., Niederwieser D. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009, 43:275-291.
5. Hambach L., Spierings E., Goulmy E. Risk assessment in hematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract Res Clin Haematol 2007, 20:171-187.
6. Dickinson A.M. Non-HLA genetics and predicting outcome in HSCT. Int J Immunogenet 2008, 35:375-380.
7. Shaw B.E., Arguello R., Garcia-Sepulveda C.A., Madrigal J.A. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. Br J Haematol 2010, 150:251-258.
8. Schlenk R.F., Döhner K., Mack S., et al. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J Clin Oncol 2010, 28:4642-4648.
9. Varney M.D., Lester S., McCluskey J., Gao X., Tait B. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Human Immunol 1999, 60:532-538.
10. Sasazuki T., Juji T., Morishima Y., et al. Effect of matching of HLA class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998, 339:1177-1785. Erratum in N Engl J Med. 1999;340:402.
11. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923-1930.
12. Loiseau P., Busson M., Balere M.L., et al. HLA association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007, 13:965-974.
13. Ludajic K., Balavarca Y., Bickeböller H., et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J Haematol 2008, 142:436-443.
14. Shaw B.E., Marsh S.G., Mayor N.P., Russell N.H., Madrigal J.A. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006, 107:1220-1226.
15. Shaw B.E., Gooley T.A., Malkki M., et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007, 110:4560-4566.
16. Lee S.J., Klein J., Haagenson M., et al. High resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
17. Kawase T., Matsuo K., Kashiwase K., et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanisms. Blood 2009, 113:2851-2858.
18. Shaw B.E., Mayor N.P., Russell N.H., et al. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia 2010, 24:58-65.
19. Ahmad T., Neville M., Marshall S.E., et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 2003, 12:647-656.
20. Miretti M.M., Walsh E.C., Ke X., et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005, 76:634-646.
21. Malkki M., Single R., Carrington M., Thomson G., Petersdorf E. MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, HLA-DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies. Tissue Antigens 2005, 66:114-124.
22. Tay G.K., Witt C.S., Christiansen F.T., Charron D., Baker D., Herrmann R., et al. Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation. Bone Marrow Transplant 1995, 15:381-385.
23. Li S., Kawata H., Katsuyama Y., et al. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at 5 HLA loci. Tissue Antigens 2004, 63:362-368.
24. Malkki M., Gooley T.A., Horowitz M.M., et al. Mapping MHC-resident transplantation determinants. Biol Blood Marrow Transpl 2007, 13:986-995.
25. Parmar S., Del Lima M., Zou Y., et al. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood 2009, 114:2884-2887.
26. Guo Z., Hood L., Malkki M., Petersdorf E.W. Long-range multilocus haplotype phasing of the MHC. Proc Natl Acad Sci USA 2006, 103:6964-6969.
27. Petersdorf E.W., Malkki M., Gooley T.A., Martin P.J., Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med 2007, 4:59-68.
28. Zino E., Frumento G., Marktel S., et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004, 103:1417-1424.
29. Zino E., Vago L., Di Terlizzi S., et al. Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13:1031-1040.
30. Crocchiolo R., Zino E., Vago L., et al. Nonpermissive HLA-DPB1 disparity is a significant independant risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009, 114:1437-1444.
31. Malkki M, Harding A, Cheng S, et al. Disparity for Class I, III II microsatellite markers in unrelated hematopoietic cell transplantation. In: Hansen JA, Dupont D, eds. Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Congress. Seattle, WA: Seattle IHWS Press, 2004:1368-1371.
32. Bettens F., Nicoloso de Faveri G., Tiercy J.-M. HLA-B51 and haplotypic diversity of B-Cw associations: implications for unrelated hematopoietic stem cell transplantation. Tissue Antigens 2009, 73:316-325.
33. Bettens F., Passweg J., Gratwohl A., et al. Association of TNFd and IL-10 polymorphisms with mortality in unrelated stem cell transplantation. Transplantation 2006, 81:1261-1267.
34. Gratwohl A., Stern M., Brand R., et al. European Group for Blood and Marrow Transpolantation and the European Leukemia Net. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer 2009, 115:4715-4726.
35. Morishima S., Ogawa S., Matsubara A., et al. Impact of highly conserved HLA haplotype on acute graft-versus-host disease. Blood 2010, 115:4664-4670.
36. Keen L.J., DeFor T.E., Bidwell J.L., Davies S.M., Bradley B.A., Hows J.M. Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant mortality after unrelated donor stem cell transplantation. Blood 2004, 103:3599-3602.
37. Goyal R.K., Lin Y., Schulz K.R., et al. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a pediatric blood and marrow transplant consortium study. Biol Blood Marrow Transplant 2010, 16:927-936.
38. Nordlander A., Uzunel M., Mattsson J., Remberger M. The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation. Br J Haematol 2002, 119:1133-1136.
39. Rollinger-Holzinger I., Eibl B., Pauly M., Griesser U., Hentges F., Auer B. LST1: a gene with extensive alternative splicing and immunomodulatory function. J Immunol 2000, 164:3169-3176.
40. Dickinson A.M., Pearce K.F., Norden J., et al. Impact of genomic risk factors for outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia. Haematologica 2010, 95:922-927.
41. Hirv K., Bloch K., Fischer M., Einsiedler B., Schrezenmeier H., Mytilineos J. Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies. Bone Marrow Transplant 2009, 44:433-440.
42. Confer D.L., Abress L.K., Navarro W., Madrigal A. Selection of adult unrelated hematopoietic stem cell donors: beyond HLA. Biol Blood Marrow Transplant 2010, 16(Suppl 1):S8-S11.